Search
-
Equality Lounge: SXSW 2022
Ipsos is proud to be an official partner of the FQ Equality Lounge, advancing equality together with other leading and forward-thinking brands.
-
Ipsos Core Political : Presidential Approval Tracker (02/16/2022)
This week’s Ipsos’ Core Political illustrates President Biden’s waning support among Republicans and independents on specific issues as his overall approval rating stands at 44% this week.
-
Americans appreciate the benefits of the tech industry, but express concerns about social media
Two Ipsos surveys investigate impressions of the tech sector, possible solutions to the problems the industry faces, and how partisanship impacts both.
-
Ipsos leaders named among the 50 most influential people in social analytics
Sandro Kaulartz, chief research officer for Ipsos SIA, and Steve Reeves, VP of Healthcare Digital Strategy & Social Intelligence in Ipsos’ Healthcare organization, honored on the Social Intelligence Lab’s first-ever Social Intelligence Insider 50
-
Ipsos Core Political : Presidential Approval Tracker (02/09/2022)
This week’s Ipsos’ Core Political shows that Americans remain mostly disapproving of President Joe Biden’s performance in office.
-
Americans support a diplomatic boycott of the Winter Olympics
COVID is not the only reason why this year’s games are different.
-
Conquering Complexity: The ongoing revolution in oncology biomarker testing
The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalized medicine now well-entrenched in the treatment paradigm.
-
Ipsos Core Political : Presidential Approval Tracker (02/03/2022)
Over half of Americans report disapproval of Joe Biden’s presidential performance
-
What the Future: Wellness
Revisit our on demand webinar to hear exclusive new data, and expert interviews with CVS Health, Unilever, Lumen, and other players driving the future of wellness.
-
COVID-19 exposes weak points in the medicine supply chain
Four in five physicians in new poll say they faced potential medicine shortages during the pandemic